Clinical trial on blood glucose level in diabetic patients.

A Prospective, open-label clinical study to evaluate the safety and efficacy of Auretics Sugar Management Spray in stabilizing blood glucose levels in Diabetic patients. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/03/081737

Enrollment

Registered

2025-03-06

Start date

Unknown

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E089- Diabetes mellitus due to underlying condition without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject Between 30 years to 60 years of both genders. 2. Diabetic subjects on anti diabetic medication. 3. Subject who are hypertensive 4. Subject free from infection, cancer and other diseases 5. Subject willing to give written Informed Consent 6.FAsting Blood Glucose level between 110 mg/dl to 250 mg/dl 7.Post Parandial Blood Sugar level between 140 mg/dl to 350 mg/dl

Exclusion criteria

Exclusion criteria: 1.Subjects with diabetes mellitus along with other comorbid conditions. 2.Pregnant or lactating women 3. Women of childbearing potential who do not take adequate contraceptive protection 4.History of hypersensitivity to the metformin or to drug with similar chemical structure 5.History of any severe systemic disease 6.Patients with uncontrolled hypertension 7.History of stroke, cancer, acute illness

Design outcomes

Primary

Measure	Time frame
Primary out Come: 1.To evaluate the efficacy of Auretics Sugar Management Spray in stabilizing Blood Sugar in Diabetic patients. 2. Decrease in Blood Sugar Level- Fasting blood sugar (FBS), Post Prandial Blood Sugar (PPBS) Glycated hemoglobin (HbA1c) and Urine Sugar from Day 0 to Day 90Timepoint: Evaluation from baseline to day 30, day 60 and day 90	—

Secondary

Measure	Time frame
Secondary Outcome: To evaluate the safety and consumer acceptance of Auretics Sugar Management Spray in stabilizing blood glucose levels in Diabetic patients through feedback questionnaires Timepoint: Baseline and Day 90	—

Countries

India

Contacts

Public ContactArjun Gupta

Auretics Limited

arjun@auretics.com9999112999

Outcome results